ARL3 and neoplasm: HBx increases m6A modification of circ-ARL3, a factor which binds tumour-suppressive miRNA-1305 and enhances the activity of oncogenes, resulting in the interaction of circ-ARL3 with YTHDC1 and increased biogenesis (Figure 4(A)) [56].